Saturated fatty acids enhance osteoclast survival

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 892-899

  Oh, So Ra ^a   Sul, Ok Joo ^a   Kim, Youn Young ^a   Kim, Hye Jin ^a   Yu, Rina ^a   Suh, Jae Hee ^b   Choi, Hye Seon ^a  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Mip 1 ; Myeloid differentiation factor 88; Osteoclast survival; Saturated fatty acid; Toll like receptor 4

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAURIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYELOID DIFFERENTIATION FACTOR 88; OSTEOCLAST DIFFERENTIATION FACTOR; PALMITIC ACID; SATURATED FATTY ACID; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; BONE METABOLISM; CELL SURVIVAL; CONTROLLED STUDY; MALE; NONHUMAN; OBESITY; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; BONE MARROW; CELL SURVIVAL; CHEMOKINE CCL3; FATTY ACIDS; GENE KNOCKOUT TECHNIQUES; MALE; MICE; MYELOID DIFFERENTIATION FACTOR 88; OBESITY; OSTEOCLASTS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 77951063837     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800626     Document Type: Article

References (37)

1. Parhami, F., Y. Tintut, W. G. Beamer, N. Gharavi, W. Goodman, and L. L. Demer. 2001. Atherogenic high-fat diet reduces bone mineralization in mice. J. Bone Miner. Res. 16: 182-188.
2. Tintut, Y., S. Morony, and L. L. Demer. 2004. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler. Thromb. Vasc. Biol. 24: e6-e10.
3. Uzzan, B., R. Cohen, P. Nicolas, M. Cucherat, and G. Y. Perret. 2007. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone. 40: 1581-1587. (Pubitemid 46779004)
4. Gutierrez, G. E., J. R. Edwards, I. R. Garrett, J. S. Nyman, B. McCluskey, G. Rossini, A. Flores, D. B. Neidre, and G. R. Mundy. 2008. Transdermal lovastatin enhances fracture repair in rats. J. Bone Miner. Res. 23: 1722-1730.
5. Johnson, G. B., B. L. Riggs, and J. L. Platt. 2004. A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J. 18: 1282-1284.
6. Cui, L-H., M-H. Shin, E-K. Chung, Y-H. Lee, S-S. Kweon, K-S. Park, and J-S. Choi. 2005. Association between bone mineral densities and serum lipid profiles of pre-and post-menopausal rural women in South Korea. Osteoporos. Int. 16: 1975-1981.
7. Verma, S., J. H. Rajaratnam, J. Denton, J. A. Hoyland, and R. J. Byers. 2002. Adipositic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 55: 693-698.
8. Yeung, D. K. W., J. F. Griffi th, G. E. Antonio, F. K. H. Lee, J. Woo, and P. C. Leung. 2005. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J. Magn. Reson. Imaging. 22: 279-285.
9. Ferrante, A. W., Jr. 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262: 408-414.
10. Boden, G. 2008. Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 37: 635-646.
11. Lee, J. Y., K. H. Sohn, S. H. Rhee, and D. Hwang. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276: 16683-16689.
12. Nguyen, M. T., S. Favelyukis, A-K. Nguyen, D. Reichart, P. A. Scott, A. Jenn, R. Liu-Bryan, C. K. Glass, J. G. Neels, and J. M. Olefsky. 2007. A subpopulation of macrophages infiltrates hypertropic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282: 35279-35292.
13. Wellen, K. E., and G. S. Hotamisligil. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115: 1111-1119.
14. Roodman, G. D. 1996. Advances in bone biology: the osteoclast. Endocr. Rev. 17: 308-332.
15. Shin, H. H., J. E. Lee, E. A. Lee, B. S. Kwon, and H. S. Choi. 2006. Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10. J. Bone Miner. Res. 21: 1907-1912.
16. -ΔΔCt method. Methods. 25: 402-408.
17. Glantschnig, H., J. E. Fisher, G. Wesolowski, G. A. Rodan, and A. A. Reszka. 2003. M-CSF, TNF-α and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ. 10: 1165-1177. (Pubitemid 37258582)
18. Itoh, K., N. Udagawa, K. Kobayashi, X. Li, M. Takami, N. Okahashi, N. Nishihara, and N. Takahashi. 2003. Lipopolysaccharide promotes the survival of osteoclast via toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 170: 3688-3695. (Pubitemid 36359239)
19. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9: 143-150. (Pubitemid 28361303)
20. Wong, B. R., R. Joisen, S. Y. Lee, M. Vologodskaia, R. M. Steinman, and Y. Choi. 1998. The TRAF family of signal transducers mediates NF-κB activation by TRANCE receptor. J. Biol. Chem. 273: 28355-28359.
21. Okamatsu, Y., D. Kim, R. Battaglino, H. Sasaki, U. Spate, and P. Stashenko. 2004. MIP-1γ, promotes receptor activator of NF-κB ligandinduced osteoclast formation and survival. J. Immunol. 173: 2084-2090. (Pubitemid 38971646)
22. Pontes Andersen, C. C., K. Buschard, A. Flyvberg, K. Stoltze, and P. Holmstrup. 2006. Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki rats. J. Periodontol. 77: 350-356.
23. Pontes Andersen, C. C., A. Flyvberg, K. Buschard, and P. Holmstrup. 2007. Periodontitis is associated with aggrevation of prediabetes in Zucker fatty rats. J. Periodontol. 78: 559-565.
24. Bagger, Y. Z., L. B. Tanko, P. Alexandersen, G. Qin, and C. Christiansen. 2006. Radiographic measure of aorta calcification is a site-specifi c predictor of bone loss and fracture risk at the hip. J. Intern. Med. 259: 598-605.
25. Schulz, E., K. Arfai, X. Liu, J. Sayre, and V. Gilsanz. 2004. Aortic calcification and the risk of osteoporosis and fractures. J. Clin. Endocrinol. Metab. 89: 4246-4253.
26. Cornish, J., A. MacGibborn, J. Lin, M. Watson, P. C. Tong, J. E. Dunford, Y. van der Does, G. A. Williams, A. B. Grey, D. Naot, et al. 2008. Modulation of osteoclastogenesis by fatty acids. Endocrinology. 149: 5688-5695.
27. Rahman, M. M., A. Bhattacharya, and G. Fernandes. 2006. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. J. Lipid Res. 47: 1739-1748.
28. Ulevitch, R. J. 2000. Molecular mechanisms of innate immunity. Immunol. Res. 21: 49-54.
29. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176: 485-494.
30. Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation of toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169: 1516-1523. (Pubitemid 34809198)
31. Nair, S. P., S. Meghji, M. Wilson, K. Reddi, P. White, and B. Henderson. 1996. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64: 2371-2380.
32. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11: 115-122.
33. Choi, S. J., Y. Oba, Y. Gazitt, M. Alsina, J. Cruz, J. Anderson, and G. D. Roodman. 2001. Antisense inhibition of macrophage-inflammatory protein-1α blocks bone destruction in a model of myeloma bone disease. J. Clin. Invest. 108: 1833-1841.
34. Choi, S. J., J. C. Cruz, F. C. Craig, H. Chung, R. D. Devlin, D. Roodman, and M. Alsina. 2000. Macrophage inflammatory protein-1α is a potential osteoclast stimulatory factor in multiple myeloma. Blood. 96: 671-675.
35. Lee, J. E., H. H. Shin, E. A. Lee, T. V. Phan, and H. S. Choi. 2007. Stimulation of osteoclastogenesis by enhanced level of MIP-1α in BALB/c mice. Exp. Hematol. 35: 1100-1108.
36. Wright, L. M., W. Maloney, X. Yu, L. Kindle, P. Collins-Osdoby, and P. Osdoby. 2005. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recritment, development and survival of human osteoclsts. Bone. 36: 840-853.
37. Gerhardt, C. C., I. A. Romero, R. Cancello, L. Camoin, and A. D. Strosberg. 2001. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol. Cell. Endocrinol. 175: 81-92.